You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Investigational Drug Information for ASP0367


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug ASP0367?

ASP0367 is an investigational drug.

There have been 7 clinical trials for ASP0367. The most recent clinical trial was a Phase 1 trial, which was initiated on May 17th 2021.

The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Renal Insufficiency. The leading clinical trial sponsors are Astellas Pharma Global Development, Inc., Astellas Pharma Inc, and [disabled in preview].

Recent Clinical Trials for ASP0367
TitleSponsorPhase
A Study to Evaluate an ASP0367 Solution in Healthy Male ParticipantsAstellas Pharma Global Development, Inc.Phase 1
A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy PeopleAstellas Pharma Global Development, Inc.Phase 1
A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic FunctionAstellas Pharma Global Development, Inc.Phase 1

See all ASP0367 clinical trials

Clinical Trial Summary for ASP0367

Top disease conditions for ASP0367
Top clinical trial sponsors for ASP0367

See all ASP0367 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.